Chronic Chagas disease (CD) affects around 3.7 million Brazilians according to the most recent estimative. As around 30-40% of this population present with the cardiac form, it comes as no surprise that CD is the third most frequent etiology among patients undergoing heart transplant in Brazil. As induction and/or maintenance immunosuppressive therapy carry the risk of CD reactivation (CDR), heart transplant safety could be questioned in CD. However, the experience in Brazil established heart transplants as the leading alternative treatment […]